Managers / Q3 2024 · view latest →
Michelson Medical Research Foundation, Inc.
CIK 0001965304 · 11755 WILSHIRE BLVD., SUITE 1400, LOS ANGELES, CA, 90025 · (310) 806-9700
Summary
Michelson Medical Research Foundation, Inc. reported $142M in U.S.-listed holdings across 28 positions for Q3 2024.
The portfolio is heavily concentrated: IVE alone accounts for 20.8% of reported value.
Compared with Q2 2024, the fund opened 4 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 66.0% · $94M
- REIT · 15.5% · $22M
- Common Stock · 14.7% · $21M
- ADR · 3.2% · $4M
- Closed-End Fund · 0.7% · $950,150
Quarter-over-Quarter Changes full breakdown →
vs Q2 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MTNVAIL RESORTS INC | NEW | +50.0K | 50.0K | +$9M | $9M |
| CMPCOMPASS MINERALS INTL INC | NEW | +505.0K | 505.0K | +$6M | $6M |
| RTORENTOKIL INITIAL PLC | NEW | +180.0K | 180.0K | +$4M | $4M |
| EPAMEPAM SYS INC | NEW | +10.0K | 10.0K | +$2M | $2M |
| SUISUN CMNTYS INC | ADDED | +29.0K | 50.0K | +$4M | $7M |
| MCHIISHARES TR | SOLD OUT | −80.0K | 0 | −$3M | $0 |
| AVBAVALONBAY CMNTYS INC | TRIMMED | −25.2K | 16.3K | −$5M | $4M |
| BURBURFORD CAP LTD | ADDED | +60.0K | 180.0K | +$820,800 | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IVEISHARES TR | S&P 500 VAL ETF · CORE S&P500 ETF · ISHARES BIOTECH · MICRO-CAP ETF | 20.84% | $30M | 145.7K |
| 2 | VEAVANGUARD TAX-MANAGED FDShistory → | VAN FTSE DEV MKT | 13.45% | $19M | 361.2K |
| 3 | VWOVANGUARD INTL EQUITY INDEX Fhistory → | FTSE EMR MKT ETF | 7.98% | $11M | 236.6K |
| 4 | KRESPDR SER TR | S&P REGL BKG · S&P BIOTECH | 6.76% | $10M | 146.0K |
| 5 | GDXVANECK ETF TRUSThistory → | GOLD MINERS ETF | 6.58% | $9M | 234.3K |
| 6 | EWZISHARES INC | MSCI BRAZIL ETF · MSCI MEXICO ETF · MSCI TAIWAN ETF · MSCI JPN ETF NEW · MSCI STH KOR ETF | 6.24% | $9M | 190.8K |
| 7 | MTNVAIL RESORTS INChistory → | COM | 6.14% | $9M | 50.0K |
| 8 | SUISUN CMNTYS INChistory → | COM | 4.76% | $7M | 50.0K |
| 9 | CMPCOMPASS MINERALS INTL INChistory → | COM | 4.28% | $6M | 505.0K |
| 10 | PLDPROLOGIS INC.history → | COM | 3.77% | $5M | 42.4K |
| 11 | RTORENTOKIL INITIAL PLChistory → | SPONSORED ADR | 3.16% | $4M | 180.0K |
| 12 | VBVANGUARD INDEX FDShistory → | SMALL CP ETF | 3.16% | $4M | 18.9K |
| 13 | AREALEXANDRIA REAL ESTATE EQ INhistory → | COM | 3.12% | $4M | 37.2K |
| 14 | AVBAVALONBAY CMNTYS INChistory → | COM | 2.59% | $4M | 16.3K |
| 15 | BURBURFORD CAP LTDhistory → | ORD SHS | 1.68% | $2M | 180.0K |
| 16 | EPAMEPAM SYS INChistory → | COM | 1.40% | $2M | 10.0K |
| 17 | BXPBXP INChistory → | COM | 1.23% | $2M | 21.7K |
| 18 | CRGYCRESCENT ENERGY COMPANYhistory → | CL A COM | 1.21% | $2M | 156.2K |
| 19 | GXCSPDR INDEX SHS FDS | S&P CHINA ETF | 0.97% | $1M | 16.8K |
| 20 | NMLNEUBERGER BERMAN ENERGY INFR | COM | 0.67% | $950,150 | 115.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $99M | 21 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $100M | 20 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $115M | 20 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $104M | 20 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $120M | 25 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $119M | 28 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $142M | 28 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $116M | 25 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $165M | 28 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $152M | 28 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $148M | 27 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $141M | 20 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $128M | 21 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $154M | 31 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.